Proteons in the Proteometer

THE CANARY IN

THE FERMENTOR

Expedite Molecular Structure Analysis With The Proteometer™!

Novilytic Canary
Arrow Down

SOLUTIONS

Bars with Logos.jpg
CONVERTING LCs INTO PROTEOFORM ANALYSIS PLATFORMS

New "Proteometer Kit" - Coming Fall 2022

PHOTO%201_edited.jpg
NOVIPLEX™ PLASMA COLLECTION SOLUTIONS
(NOW TELIMMUNE)

Advanced Remote

Plasma Collection

Purchase at Telimmune.com

Lifestyle 2.jpg

ENHANCED APPROACH TO PROCESS ANALYTICAL TECHNOLOGY

Save Time and Money With Mobile Affinity Sorbent Chromatography (MASC™)

Bioreactor Banner Option 1 - pcd22Jul202

ABOUT

Novilytic is a molecular recognition company that utilizes nanotechnology to protect lifesaving drugs.

 

Our flagship technology is The Proteometer, the world’s first instrument capable of Molecular Structure Analysis of proteoforms in process. It is a solution that can lead to increased FDA compliance while saving time and money.

 

We are currently developing Nanotechnology Kits that will turn a liquid chromatograph (LC) into a Proteometer capable of real-time proteoform analysis on post-translational modifications.

 

TESTIMONIALS

Architectural Structure

“The Proteometer is expected to play a central role in the development and commercialization of next-level biological manufacturing control strategies.

Eugene L. Inman, Ph.D.

Pharmaceutical Quality Consultant

Retired Eli Lilly and Company

Architectural Structure

“Novilytic’s Proteometer is a disruptive breakthrough that finally solves the FDA's requirement to continuously monitor t-mAb proteoforms during fermentation.”

Martin Long, BSc.
Performance Validation, Inc. – President & CEO
(Analytical Sciences Business, Brooks Life Sciences, Thermo, Perkin Elmer)

Architectural Structure

“We couldn’t be more thrilled by the results of our validation and stability analyses using the NoviPlex dry plasma cards and look forward to using them in our DMD clinical trial.”

Ines Macias-Perez, Ph.D

Principle Scientist, Product Development

Cumberland Pharmaceuticals

> 5,000

Bioreactors Globally

$8M

Raw Material Costs

0 PAT In-Line

Massive Industry Gap

The Proteometer Provides the Solution